Abstract
Gestational diabetes mellitus (GDM) affects 14% of pregnancies worldwide with adverse maternal and offspring outcomes. Fetal sex is known to influence pregnancy outcomes and shape placental function. Although the placenta plays a central role in regulating maternal glucose levels, the molecular mechanisms driving GDM pathophysiology—and how they vary by fetal sex—are incompletely understood. We examined fetal sex impact on placental gene programs in GDM using two independent cohorts. In a case-control study (N = 101, 42 with GDM), we assessed expression of eight glycemic/immune regulation genes via qPCR in GDM placentas versus sex-matched controls. In a second prospective cohort of 433 individuals (N = 35 with GDM), we performed sex-stratified transcriptomic analyses of placental RNA-Seq data. Placental expression of genes implicated in glucose metabolism (IGFBP1, RBP4, EPYC, and PRL) was sexually dimorphic in GDM versus sex-matched controls. Transcriptomic analyses revealed enrichment in proinflammatory/glycolytic pathways and dysregulated retinoic acid signaling in male GDM placentas, while female GDM placentas showed enrichment in cell growth and immunoregulatory pathways. GDM elicits sex-specific differences in placental gene programs, highlighting the importance of incorporating fetal sex in pregnancy studies. These findings may inform future sex-tailored strategies for offspring risk prediction and intervention in GDM.
Data availability
The Gen3G placental RNA-seq data are available on dbGAP ( https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs003151.v1.p1). The R code supporting the conclusions of the manuscript is available on GitHub (https://github.com/labjacquespe/diff-exp and https://github.com/labjacquespe/GO-analysis).
References
Gregory, E. & Ely, D. Trends and Characteristics in Prepregnancy Diabetes: United States, 2016–2021. https://stacks.cdc.gov/view/cdc/127679https://doi.org/10.15620/cdc:127679 (2023).
Sweeting, A. et al. Epidemiology and management of gestational diabetes. Lancet 404, 175–192 (2024).
Varner, M. W. et al. Pregnancies after the diagnosis of mild gestational diabetes mellitus and risk of cardiometabolic disorders. Obstet. Gynecol. 129, 273–280 (2017).
Tam, W. H. et al. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care. 40, 679–686 (2017).
Hufnagel, A., Dearden, L., Fernandez-Twinn, D. S. & Ozanne, S. E. Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia. J. Endocrinol. 253, R47–R63 (2022).
O’Tierney-Ginn, P. Let’s talk about sex: placentas’ central role in sexually dimorphic responses to the maternal milieu. J. Clin. Endocrinol. Metabol. 105, e4973-4 (2020).
Meakin, A. S., Cuffe, J. S. M., Darby, J. R. T., Morrison, J. L. & Clifton, V. L. Let’s talk about placental sex, baby: Understanding mechanisms that drive Female- and Male-Specific fetal growth and developmental outcomes. Int J. Mol. Sci 22, (2021).
Baines, K. J. & West, R. C. Sex differences in innate and adaptive immunity impact fetal, placental, and maternal health. Biol. Reprod. 109, 256–270 (2023).
Barke, T. L. et al. Sex modifies placental gene expression in response to metabolic and inflammatory stress. Placenta 78, 1–9 (2019).
Shook, L. L. et al. Sex-specific impact of maternal obesity on fetal placental macrophages and cord blood triglycerides. Placenta 140, 100–108 (2023).
Sun, T. et al. Sexually dimorphic crosstalk at the maternal-fetal interface. J. Clin. Endocrinol. Metab. 105, e4831–e4847 (2020).
Saoi, M., Kennedy, K. M., Gohir, W., Sloboda, D. M. & Britz-McKibbin, P. Placental metabolomics for assessment of sex-specific differences in fetal development during normal gestation. Sci. Rep. 10, 9399 (2020).
Persson, M. & Fadl, H. Perinatal outcome in relation to fetal sex in offspring to mothers with pre-gestational and gestational diabetes–a population-based study. Diabet. Med. 31, 1047–1054 (2014).
Le Moullec, N. et al. Sexual dimorphism in the association between gestational diabetes mellitus and overweight in offspring at 5–7 years: the OBEGEST cohort study. PLoS One. 13, e0195531 (2018).
Coles, N. et al. Determinants of insulin resistance in children exposed to gestational diabetes in utero. Pediatr. Diabetes. 21, 1150–1158 (2020).
Saito, Y. et al. Neurodevelopmental delay up to the age of 4 years in infants born to women with gestational diabetes mellitus: the Japan environment and children’s study. J. Diabetes Investig. 13, 2054–2062 (2022).
Kedziora, S. M. et al. Placental transcriptome profiling in subtypes of diabetic pregnancies is strongly confounded by fetal sex. Int. J. Mol. Sci. 23, (2022).
Aljani, B. et al. Gene expression profiles in placenta and their association with anesthesia, delivery mode and maternal diabetes. Placenta 158, 126–135 (2024).
Alexander, J. et al. Offspring sex impacts DNA methylation and gene expression in placentae from women with diabetes during pregnancy. PLoS One. 13, e0190698 (2018).
Hivert, M. F. et al. Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes. Nat. Med. https://doi.org/10.1038/s41591-024-02936-5 (2024).
Thaweethai, T., Soetan, Z., James, K., Florez, J. C. & Powe, C. E. Distinct insulin physiology trajectories in euglycemic pregnancy and gestational diabetes mellitus. Diabetes Care. 46, 2137–2146 (2023).
Sordillo, J. E. et al. Higher maternal body mass index is associated with lower placental expression of EPYC: A Genome-Wide transcriptomic study. J. Clin. Endocrinol. Metab. https://doi.org/10.1210/clinem/dgad619 (2023).
Leca, B. M. et al. Retinol-binding protein 4 (RBP4) circulating levels and gestational diabetes mellitus: a systematic review and meta-analysis. Front. Public. Health. 12, 1348970 (2024).
Soares, M. J. The prolactin and growth hormone families: pregnancy-specific hormones/cytokines at the maternal-fetal interface. Reprod. Biol. Endocrinol. 2, 51 (2004).
Kawai, V. K. et al. Variation in the α2A-adrenergic receptor gene and risk of gestational diabetes. Pharmacogenomics 18, 1381–1386 (2017).
Meller, M., Vadachkoria, S., Luthy, D. A. & Williams, M. A. Evaluation of housekeeping genes in placental comparative expression studies. Placenta 26, 601–607 (2005).
Motulsky, H. J. & Brown, R. E. Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinform. 7, 123 (2006).
Guillemette, L. et al. Genetics of glucose regulation in gestation and growth (Gen3G): a prospective prebirth cohort of mother-child pairs in Sherbrooke, Canada. BMJ Open. 6, e010031 (2016).
Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012).
Miller, D., Gershater, M., Slutsky, R. Romero, R. & Gomez-Lopez, N. Maternal and fetal T cells in term pregnancy and preterm labor. Cell. Mol. Immunol. 17, 693–704 (2020).
Oike, Y. et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat. Med. 11, 400–408 (2005).
Namkung, J. et al. Increased serum angiopoietin-like 6 ahead of metabolic syndrome in a prospective cohort study. Diabetes Metab. J. 43, 521–529 (2019).
Arunachalam, P. S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369, 1210–1220 (2020).
Boon, C. J. F. et al. The spectrum of phenotypes caused by variants in the CFH gene. Mol. Immunol. 46, 1573–1594 (2009).
Laurencikiene, J. & Rydén, M. Liver X receptors and fat cell metabolism. Int. J. Obes. (Lond). 36, 1494–1502 (2012).
Muscat, G. E. O. et al. Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors. J. Biol. Chem. 277, 40722–40728 (2002).
Schulman, I. G. Liver X receptors link lipid metabolism and inflammation. FEBS Lett. 591, 2978–2991 (2017).
Berenguer, M. et al. Prenatal retinoic acid exposure reveals candidate genes for craniofacial disorders. Sci. Rep. 8, 17492 (2018).
Radhika, M. S. et al. Effects of vitamin A deficiency during pregnancy on maternal and child health. BJOG 109, 689–693 (2002).
Spiegler, E., Kim, Y. K., Wassef, L., Shete, V. & Quadro, L. Maternal-fetal transfer and metabolism of vitamin A and its precursor β-carotene in the developing tissues. Biochim. Biophys. Acta. 1821, 88–98 (2012).
Huebner, H. et al. Expression and regulation of retinoic acid receptor responders in the human placenta. Reprod. Sci. 25, 1357–1370 (2018).
Yang, Q. et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436, 356–362 (2005).
Wang, F. et al. Retinol-binding protein 4 regulates the biological functions and molecular mechanisms of JEG-3 cells. Int. J. Clin. Exp. Pathol. 11, 5877–5884 (2018).
Li, H. et al. RBP4 regulates trophoblastic cell proliferation and invasion via the PI3K/AKT signaling pathway. Mol. Med. Rep. 18, 2873–2879 (2018).
Tarrade, A. et al. Sexual dimorphism of the feto-placental phenotype in response to a high fat and control maternal diets in a rabbit model. PLoS One. 8, e83458 (2013).
Stunes, A. K. et al. Maternal vitamin A and D status in second and third trimester of pregnancy and bone mineral content in offspring at nine years of age. Front. Endocrinol. (Lausanne). 15, 1417656 (2024).
Gutiérrez-Vega, S. et al. High levels of maternal total tri-iodothyronine, and low levels of fetal free L-thyroxine and total tri-iodothyronine, are associated with altered deiodinase expression and activity in placenta with gestational diabetes mellitus. PLoS One. 15, e0242743 (2020).
Yura, S. et al. Resistin is expressed in the human placenta. J. Clin. Endocrinol. Metab. 88, 1394–1397 (2003).
Lobo, T. F., Torloni, M. R., Gueuvoghlanian-Silva, B. Y., Mattar, R. & Daher, S. Resistin concentration and gestational diabetes: a systematic review of the literature. J. Reprod. Immunol. 97, 120–127 (2013).
Chen, C. P., Chang, S. C. & Vivian Yang, W. C. High glucose alters proteoglycan expression and the glycosaminoglycan composition in placentas of women with gestational diabetes mellitus and in cultured trophoblasts. Placenta 28, 97–106 (2007).
Bordt, E. A. et al. Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses. Sci. Transl Med. 13, eabi7428 (2021).
Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 22, 1462–1470 (1999).
Funding
NIH/NICHD: 5K12HD103096 (to L.L.S.), 5R01HD100022 (to A.G.E.), R01HD094150 (to M.F.H.). Gen3G was initially supported by a Fonds de recherche du Québec – Santé (FRQS) operating grant (to M-FH, grant #20697); Canadian Institute of Health Research (CIHR) operating grants (to M-FH grant #MOP 115071 and to LB #PJT-152989); and a Diabète Québec grant. LB and PEJ are senior research scholars from the FRQS. MFH was a recipient of an American Diabetes Association (ADA) Pathways To Stop Diabetes Accelerator Award (#1-15-ACE-26).
Author information
Authors and Affiliations
Contributions
L.L.S. performed data analysis, interpreted results, and drafted the manuscript. F.W. performed bioinformatic analysis of RNA-seq data and contributed to data interpretation. S.T.B., L.I.P., D.H., and K.A. performed laboratory experiments and data analysis of the MGH cohort. F.A., K.G.A. and P.-E.J. performed RNA sequencing and contributed to bioinformatics pipeline development of the Gen3G cohort. L.B. co-led the Gen3G cohort, oversaw biospecimen processing and data interpretation. C.E.P. designed the SPRING study, provided clinical expertise, and critically revised the manuscript. S.A.K. and J.C.F critically revised the manuscript. M.-F.H. conceptualized the study, obtained funding, supervised the Gen3G cohort analysis, and critically revised the manuscript. A.G.E. conceptualized the study, obtained funding, led enrollment in the MGH cohort, supervised MGH cohort laboratory experiments and analyses, and critically revised the manuscript. All authors reviewed and approved the final version of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
C.E.P. has received fees and royalties from Mediflix and UpToDate (Wolters Kluwer), respectively, for presentations and articles related to diabetes over which she had full control of content. C.E.P. and L.L.S. have received research support from Dexcom, outside the submitted work. A.G.E. reports serving as a consultant for Mirvie, Inc and Merck Sharp and Dohme, Inc outside the submitted work. The remaining authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Shook, L.L., White, F., Acharya, K.D. et al. Fetal sex-specific differences in the placental transcriptome of gestational diabetes. Sci Rep (2026). https://doi.org/10.1038/s41598-026-39975-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-39975-6